1. Field of the Invention
The present invention relates to optical fiber components used in medical laser treatments, and in particular, to fibers for the treatment of veins with laser energy.
2. Invention Disclosure Statement
Underskin laser treatment is an effective method for eliminating many abnormalities, especially skin and vascular problems such as wrinkles and varicose veins, and provides a more proximal access to the area of treatment allowing the use of a less powerful and less harmful laser. Such treatments avoid the need to irradiate through the skin from an external source, which can damage tissue, especially the skin, producing undesired side effects such as external discoloration or scarring. Also, the risk of inadvertent exposure of surrounding tissue to radiation is reduced. Underskin laser treatments can be effective for correcting skin irregularities such as eradicating vascular abnormalities operating in various parts of the body.
One specific application of underskin laser treatments is the correction of vascular abnormalities, such as capillary disorders, spider nevus, hemangioma, and varicose veins. For the treatment of varicose veins, an optical waveguide coupled to a suitable radiation source, is typically positioned in the affected blood vessel. The blood vessel is irradiated to affect the vessel walls and close the vessel. Preferably, the waveguide, typically an optical fiber, is slowly withdrawn during irradiation, to treat and close the blood vessel along a desired length. An exemplary underskin laser treatment device and method is described in U.S. Pat. No. 6,200,332 to Del Giglio, entitled, “Device and Method for Underskin Laser Treatments” having the same assignee as the present invention and which is incorporated by reference herein.
During operation, however, the fiber may be exposed to potentially damaging conditions. For example, as the fiber is withdrawn from the vessel, the vessel closes behind it. Vessel tissue can come in contact with the tip of the fiber, affecting performance of the device and/or causing unwanted damage to the patient, such as perforation of the vein or bruising the patient.
U.S. Application No. 2003/0236517 A1 (Appling et al.) describes an endovascular treatment device including an optical fiber and a protective sleeve, which are axially movable relative to one another. The optical fiber is positioned within the sleeve so that the distal end is in a protected state during insertion of the sleeve into a blood vessel or into a sheath positioned within the blood vessel. After insertion, the sleeve is retracted so that the distal end of the fiber is exposed (operating position) during irradiation. The protective sleeve provides protection to both the distal end of the fiber and the blood vessel or sheath during insertion. Although the protective sleeve may protect the optical fiber while the assembly is inserted into a vessel, once the sleeve is moved to an “operating state” the fiber is exposed and can be damaged.
U.S. Application No. 2004/0010248 A1 (Appling et al.) discloses an endovascular laser treatment device to treat venous diseases such as varicose veins. The device includes a spacer that positions the distal end of the optical fiber away from the inner wall of the blood vessel during delivery of laser energy. For example, a ceramic sleeve can extend over and be spaced radially away from the fiber tip to prevent vessel wall contact. The spacer is used to provide an even distribution of thermal energy around the vessel. The positioning of the spacer, however, still leaves the fiber tip vulnerable to potential contact with vessel tissue during treatment. In addition, there is the possibility of perforation of the vessel, particularly before the vein walls collapse.
In U.S. Application No. 2005/0131400 A1, Hennings et al. disclose an endovascular optical fiber comprising an opaque protective spacer which surrounds the fiber's tip. As an example, a ring shaped polymer extends over the fiber's tip in order to prevent vessel wall contact.
Thus, there is a need to have a device and/or method for underskin radiation treatment wherein damage to the fiber during operation is minimized, or eliminated. The present invention addresses this need.
It is an objective of the present invention to provide an improved intravascular laser treatment device with an optical waveguide having a core, a cladding layer and a tip configured to protect the core, for example, from contact with collapsing vein walls during laser vein treatments.
It is another objective of currently preferred embodiments of the present invention to recess the clad-core within one or more jacketing layers to protect the core.
It is still another objective of currently preferred embodiments of the present invention to have a rounded tip for the jacketing layer extending distally past core-clad layer thus avoiding the need for a catheter and/or introducers.
It is yet another objective of currently preferred embodiments of the present invention to employ at least one protective wire structure that extends distally past the core, to guide and protect the core.
It is a further objective of currently preferred embodiments of the present invention to keep the optical waveguide substantially centrally located within the vein during treatment for increased efficiency and safety.
It is still a further objective of the present invention to provide an improved method for intravascular laser treatment using an intravascular laser treatment device, wherein the core of the optical waveguide remains protected for the duration of the treatment.
Briefly stated, the present invention provides an improved device and method for safer and more efficient laser vein treatments. The device includes an optical waveguide optically coupled to a radiation source at its proximal end, having a core, a cladding layer and a tip configured to protect the clad-core, e.g., from contact with collapsing vein walls during laser vein treatment and enhance treatment efficiency through improved centering. According to one exemplary embodiment, the clad-core is recessed within one or more jacket layers. Also in some cases the protective jacket on the clad-core may be left on when the jacket layer is added. In another embodiment, one or more protective wires are attached to the clad-core or a jacket layer and extend distally past the clad-core. For example, three protective wires can be spaced evenly around the circumference of the core, i.e., forming an equilateral triangular pattern. As such, the core remains protected and generally centered for the duration of the treatment. The optical waveguide can be used in conjunction with an introducer structure having a protective means to prevent damage to the vein walls, i.e., perforating the vein walls, during insertion of the optical waveguide into the vein. A method of using the device is also disclosed herein, wherein a distal end of the optical waveguide is advanced to a desired position and essentially centered in the vein. A predetermined wavelength of radiation is output from the distal end of the optical fiber while the optical waveguide is simultaneously withdrawn from the vein. The tip of the optical waveguide protects the clad-core from contact with the collapsing vein wall during withdrawal through the vein.
The above, and other objectives, features and advantages of the present invention and of the currently preferred embodiments thereof will become apparent from the following description read in conjunction with the accompanying drawings, in which like reference numbers in the different figures designate like elements.
Optical waveguide 104 has a proximal and a distal end. The proximal end of optical waveguide 104 is optically coupled to radiation source 102, which may be any known source suitable for emitting radiation of preselected wavelengths and with sufficient power for treatment efficacy. The optimal types of radiation sources and optical waveguides are known in the art for various underskin laser treatments, and are not described further herein. Further, optical waveguide 104 will have a distal tip area as described generally below and in the embodiments presented in
The suggested range for the extension of the over-layer or other tip beyond the distal end of the core-clad face, defining the offset d, is dependent on several parameters of the system. For example, where a number of over-layers, (jackets) are used, so that the overall diameter of the distal end is very much larger than the diameter of the core within the clad-core structure, smaller offsets may be possible. The relatively larger diameter of the over-layers results in improved centering and in effectively protecting the core from the collapsing vessel wall due to the relatively large minimum distance between the outermost edge of the tip to the center area where the core resides. The numerical aperture (“NA”) of the fiber also plays a role in the degree to which the over-layer or other tip extends beyond the distal end of the core-clad face. The range suggested in the example of
As may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, numerous changes may be made to the embodiments shown and described herein without departing from the scope of the invention. For example, the embodiment of
As shown in
Protective guide wire 606 is attached to, by means such as gluing, soldering, mechanical crimping, etc., and extends distally past, clad-core 602. Protective wire 606 terminates at its distal end in hooked region 608. During laser vein treatment, hooked region 608 prevents the collapsing vein walls from coming into contact with the core, yet does not significantly obstruct the radiation emitting field. Protective guide wire may be made of metal or some other appropriate material. Since it will not displace much blood, its presence has minimal effect on the irradiation step.
Protective wire 706 is attached to glass jacketing layer 704 and extends distally past cladding layer/-core 702 and glass jacketing layer 704. As with protective wire 606 described, for example, in conjunction with the description of
Protective guide/centering wires 806, 808 and 810, as shown in
As compared to the protective wires shown, for example, in
Protective wires 906, 908 and 910 as shown in
Recessing clad-core 902 within glass jacket layer 904 gives an added layer of protection for clad-core 902. Further, attaching the protective wires to the glass jacket layer, rather than to the clad-core (see
According to an exemplary embodiment, the present laser treatment device and optical waveguide tip configurations can be used as a treatment set in conjunction with a hollow introducer, inside which the waveguide is placed, prior to treatment. Such a treatment set, having a hollow introducer structure, is described, for example, in U.S. patent application Ser. No. 11/800,865, filed by Neuberger et al., entitled “Device and Method for Improved Vascular Laser Treatment,” (hereinafter “Neuberger”), the disclosure of which is incorporated by reference herein. In Neuberger, it is disclosed that a protective means can be positioned on or in a distal end of the introducer, to prevent perforation of a vein during insertion of the waveguide set into the vein.
In step 1004, a predetermined wavelength of radiation 1014 is output from distal end 1010 of the optical waveguide. As shown in step 1006, this radiation causes the walls of vein 1012 to collapse. The waveguide tip configuration, in this case a recessed core, prevents the collapsing walls of vein 1012 from contacting the core of the optical waveguide and maintains a more uniform irradiation of the blood and vein walls.
Simultaneously with outputting radiation 1014, distal end 1010 of the optical waveguide is withdrawn from vein 1012, along direction 1016, i.e., back towards a point of entry as shown in step 1008. As described above, an important advantage of the present techniques is that the waveguide tip is configured to protect the core of the optical waveguide for the duration of the treatment of the vein.
As described above, the present laser treatment device and optical waveguide tip configurations may be used as a treatment set in conjunction with an introducer having a protective means. Accordingly, in step 1002, above, the treatment set, i.e., the optical waveguide and the introducer would be advanced to the desired position within the vein. An added step would then be required to expose the optical waveguide tip from the introducer. Several suitable techniques for accomplishing this are described in Neuberger. By way of example only, the optical waveguide can be further advanced within the introducer to pass through the protective means and extend the distal end of the optical waveguide a predetermined distance from an exit opening of the introducer.
Having described preferred embodiments of the invention with reference to the accompanying drawings, it is to be understood that the invention is not limited to the precise embodiments, and that various changes and modifications may be effected therein by one skilled in the art without departing from the scope of the invention as defined in the appended claims.
This application claims priority under 35 U.S.C. § 119 to co-pending U.S. Provisional Patent Application Ser. No. 60/932,601, filed Jun. 01, 2007, entitled “Improved Vascular Laser Treatment Device and Method”, which is hereby expressly incorporated by reference as part of the present disclosure.
Number | Date | Country | |
---|---|---|---|
60932601 | Jun 2007 | US |